Hakutulokset - Shihua Luo

  • Näytetään 1 - 3 yhteensä 3 tuloksesta
Tarkenna hakua
  1. 1
    Rapid detection of Pseudomonas aeruginosa by glycerol one-pot RAA/CRISPR-Cas12a method

    Rapid detection of Pseudomonas aeruginosa by glycerol one-pot RAA/CRISPR-Cas12a method Tekijä Lijian Wei, Lijian Wei, Lijian Wei, Lijian Wei, Lijian Wei, Lijian Wei, Shihua Luo, Shihua Luo, Shihua Luo, Shihua Luo, Shihua Luo, Weijie Zhou, Baoyan Ren, Baoyan Ren, Miao Li, Lina Liang, Lina Liang, Lina Liang, Lina Liang, Lina Liang, Xuebin Li, Xuebin Li, Xuebin Li, Xuebin Li, Guijiang Wei, Guijiang Wei, Guijiang Wei, Guijiang Wei, Guijiang Wei, Guijiang Wei

    Julkaistu 2025-07-01

    Pseudomonas aeruginosa (PA), an opportunistic pathogen commonly responsible for hospital-acquired infections, poses significant threats to human health. To enable rapid and reliable PA detection while effectively mitigating aerosol contamination risks inherent in conventional methods. We developed a...

    Täydet tiedot

    Hae kokoteksti
    Artikkeli

    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Sensitive SERS Platform for the Detection of Staphylococcus aureus via Freezing SERS Tags and Core–Shell Aptamer-Au@Fe3O4 Nanoparticles

    Sensitive SERS Platform for the Detection of Staphylococcus aureus via Freezing SERS Tags and Core–Shell Aptamer-Au@Fe3O4 Nanoparticles Tekijä Mingming Zheng, Yunju Xiao, Wenzhe Zhang, Sirui Lv, Liye Sun, Qi Wang, Junfang Zhu, Lei Chen, Hong Lin, Shihua Luo

    Julkaistu 2025-07-01 Hae kokoteksti
    Artikkeli

    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Insights into Binding Mechanisms of Potential Inhibitors Targeting PCSK9 Protein via Molecular Dynamics Simulation and Free Energy Calculation

    Insights into Binding Mechanisms of Potential Inhibitors Targeting PCSK9 Protein via Molecular Dynamics Simulation and Free Energy Calculation Tekijä Xingyu Wu, Xi Zhu, Min Fang, Fenghua Qi, Zhixiang Yin, John Z.H. Zhang, Shihua Luo, Tong Zhu, Ya Gao

    Julkaistu 2025-07-01

    The design of small-molecule inhibitors targeting proprotein convertase subtilisin/Kein type 9 (PCSK9) remains a forefront challenge in combating atherosclerosis. While various monoclonal antibodies have achieved clinical success, small-molecule inhibitors are hindered by the unique structural featu...

    Täydet tiedot

    Hae kokoteksti
    Artikkeli

    Lisää suosikkeihin
    Tallennettuna:

Työkalut: